Multifactorial Intervention to Reduce Cardiovascular Events in Type 2 Diabetes

被引:17
|
作者
Rajpathak, Swapnil N. [2 ]
Aggarwal, Vikas [2 ]
Hu, Frank B. [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA
[2] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA
关键词
Diabetes; Cardiovascular disease; Multifactorial intervention; Lifestyle intervention; Nutrition; Lipids; Obesity; Hypertension; Hypoglycemia; CORONARY-HEART-DISEASE; WHOLE-GRAIN INTAKE; GLUCOSE CONTROL; DIETARY FIBER; GLYCEMIC LOAD; COST-EFFECTIVENESS; PHYSICAL-ACTIVITY; TOTAL MORTALITY; RISK; MELLITUS;
D O I
10.1007/s11892-009-0084-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes is associated with a significantly increased risk of cardiovascular disease (CVD) morbidity and mortality. Although several clinical trials have evaluated the effects of interventions to reduce CVD risk in people with diabetes, such studies are primarily conducted to target individual risk factors such as hypertension, hyperglycemia, and dyslipidemia rather than using a multifactorial interventional approach. Existing clinical trial data suggest that intensive multifactorial interventions that target several important risk factors simultaneously result in a significantly greater risk reduction in CVD risk compared with single risk factor interventions. However, few studies have evaluated the efficacy and effectiveness of such interventions on CVD hard end points. A multidisciplinary team management of diabetes should focus on weight control, diet, physical activity, diabetes education, and adherence to pharmacotherapy. An individually tailored aggressive management program to reduce multiple CVD risk factors simultaneously has great potential to prevent CVD morbidity and mortality among patients with type 2 diabetes.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 50 条
  • [41] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes Reply
    Neal, Bruce
    Perkovic, Vlado
    Matthews, David R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21): : 2099 - 2099
  • [42] Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
    Pitt, Bertram
    Filippatos, Gerasimos
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George L.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Schloemer, Patrick
    Ruilope, Luis M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24): : 2252 - 2263
  • [43] Empagliflozin reduces cardiovascular events and mortality in type 2 diabetes
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2016, 128 (04) : 335 - 337
  • [44] Impacts of tight multifactorial intervention in patients with type 2 diabetes: Implications from the Japan Diabetes Outcome Intervention Trial 3
    Araki, Eiichi
    Senokuchi, Takafumi
    Furukawa, Noboru
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (05) : 1022 - 1024
  • [45] The Diabetes Shared Care Program and Risks of Cardiovascular Events in Type 2 Diabetes
    Kornelius, Edy
    Chiou, Jeng-Yuan
    Yang, Yi-Sun
    Lu, Ying-Li
    Peng, Chiung-Huei
    Huang, Chien-Ning
    AMERICAN JOURNAL OF MEDICINE, 2015, 128 (09): : 977 - +
  • [46] Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
    Wing, Rena
    Bolin, Paula
    Brancati, Frederick L.
    Bray, George A.
    Clark, Jeanne M.
    Coday, Mace
    Crow, Richard S.
    Curtis, Jeffrey M.
    Egan, Caitlin M.
    Espeland, Mark A.
    Evans, Mary
    Foreyt, John P.
    Ghazarian, Siran
    Gregg, Edward W.
    Harrison, Barbara
    Hazuda, Helen P.
    Hill, James O.
    Horton, Edward S.
    Hubbard, Van S.
    Jakicic, John M.
    Jeffery, Robert W.
    Johnson, Karen C.
    Kahn, Steven E.
    Kitabchi, Abbas E.
    Knowler, William C.
    Lewis, Cora E.
    Maschak-Carey, Barbara J.
    Montez, Maria G.
    Murillo, Anne
    Nathan, David M.
    Patricio, Jennifer
    Peters, Anne
    Pi-Sunyer, Xavier
    Pownall, Henry
    Reboussin, David
    Regensteiner, Judith G.
    Rickman, Amy D.
    Ryan, Donna H.
    Safford, Monika
    Wadden, Thomas A.
    Wagenknecht, Lynne E.
    West, Delia S.
    Williamson, David F.
    Yanovski, Susan Z.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02): : 145 - 154
  • [47] Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
    Craig A. Johnston
    Jennette P. Moreno
    John P. Foreyt
    Current Atherosclerosis Reports, 2014, 16
  • [48] Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
    Johnston, Craig A.
    Moreno, Jennette P.
    Foreyt, John P.
    CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (12) : 1 - 8
  • [49] Cardiovascular effects of an intensive intervention in the lifestyle of type 2 diabetes
    Garcia Giraldo, Paola Tatiana
    REVISTA CLINICA ESPANOLA, 2014, 214 (02): : 102 - 102
  • [50] Identifying Postpartum Intervention Approaches to Reduce Incidence of Type 2 Diabetes and Cardiovascular Disease in American Indian Women with Previous Gestational Diabetes
    Jones, Emily J.
    Peercy, Michael
    Fraley, Hannah
    Seely, Ellen W.
    ENDOCRINE REVIEWS, 2014, 35 (03)